Addex Therapeutics (ADXN) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$2.7 million.
- Addex Therapeutics' Enterprise Value rose 2915.3% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year increase of 2915.3%. This contributed to the annual value of -$3.8 million for FY2024, which is 1159.12% up from last year.
- Per Addex Therapeutics' latest filing, its Enterprise Value stood at -$2.7 million for Q3 2025, which was up 2915.3% from -$2.8 million recorded in Q2 2025.
- Addex Therapeutics' 5-year Enterprise Value high stood at -$490.17 for Q3 2023, and its period low was -$22.2 million during Q1 2022.
- In the last 4 years, Addex Therapeutics' Enterprise Value had a median value of -$3.9 million in 2024 and averaged -$6.8 million.
- In the last 5 years, Addex Therapeutics' Enterprise Value surged by 9999.77% in 2023 and then crashed by 78969326.74% in 2024.
- Addex Therapeutics' Enterprise Value (Quarter) stood at -$7.2 million in 2022, then skyrocketed by 39.67% to -$4.4 million in 2023, then increased by 12.31% to -$3.8 million in 2024, then rose by 28.24% to -$2.7 million in 2025.
- Its last three reported values are -$2.7 million in Q3 2025, -$2.8 million for Q2 2025, and -$7598.2 during Q1 2025.